E
Actavia Life Sciences, Inc. RASP
$0.004 -$0.0285-87.69%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2024 12/31/2023 09/30/2023 06/30/2023 03/31/2023
Net Income -95.50K -147.60K -58.30K -105.20K -4.13M
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges 15.80K 14.90K 3.90K 0.00 164.10K
Total Other Non-Cash Items 8.00K 8.00K 5.60K 4.80K 3.86M
Change in Net Operating Assets 35.90K 77.50K 55.50K 110.30K 83.90K
Cash from Operations -35.80K -47.30K 6.70K 10.00K -23.80K
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued 18.00K -- 80.00K 0.00 0.00
Total Debt Repaid 0.00 -8.50K -14.10K -9.70K -21.60K
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 18.00K -8.50K 65.90K -9.70K -21.60K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -17.80K -55.80K 72.50K 300.00 -45.30K
Weiss Ratings